Conclusions: We recommend exercising extreme caution in using SRT for R/SPMLNMs in patients who received prior RT (particularly to LN station 7). For patients without previous RT, SRT appears to be safe and efficacious treatment modality; prospective studies are warranted.Oncotarget 15691 www.impactjournals.com/oncotarget